Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 113,041 | 106,506 | 47,709 | 122,060 | 85,239 |
| Gross Profit | 113,041 | 106,506 | 47,709 | 122,060 | 85,239 |
| Operating Expenses | 33,734 | 33,933 | 40,904 | 46,576 | 39,918 |
| Operating Income | 79,307 | 72,573 | 6,805 | 75,484 | 45,321 |
| Interest Expense | 7,203 | 9,141 | 7,886 | 8,434 | 8,356 |
| Other Income | 1,627 | 1,740 | 1,536 | 970 | 857 |
| Pre-tax Income | 73,731 | 65,172 | 455 | 68,020 | 37,822 |
| Income Tax | 22,440 | 24,399 | 2,731 | 27,940 | 14,223 |
| Net Income Continuous | 51,291 | 40,773 | -2,276 | 40,080 | 23,599 |
| Net Income | $51,291 | $40,773 | $-2,276 | $40,080 | $23,599 |
| EPS Basic Total Ops | 0.31 | 0.25 | -0.02 | 0.25 | 0.15 |
| EPS Basic Continuous Ops | 0.31 | 0.25 | -0.01 | 0.25 | 0.15 |
| EPS Diluted Total Ops | 0.31 | 0.24 | 0.01 | 0.23 | 0.14 |
| EPS Diluted Continuous Ops | 0.31 | 0.24 | 0.02 | 0.23 | 0.13 |
| EPS Diluted Before Non-Recurring Items | 0.31 | 0.24 | -0.01 | 0.24 | 0.14 |
| EBITDA(a) | $79,764 | $73,016 | $7,265 | $75,959 | $45,788 |